Spots Global Cancer Trial Database for transarterial radioembolization (tare)
Every month we try and update this database with for transarterial radioembolization (tare) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE | NCT06040099 | Hepatocellular ... | Durvalumab Bevacizumab Transarterial R... | 18 Years - 130 Years | AstraZeneca | |
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE | NCT06040099 | Hepatocellular ... | Durvalumab Bevacizumab Transarterial R... | 18 Years - 130 Years | AstraZeneca | |
A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma | NCT02004210 | Hepatocellular ... | transarterial r... transarterial c... | 20 Years - 80 Years | Seoul National University Hospital |